Guangzhou Improve Med Instrument Total Assets
Guangzhou Improve Med Instrument total assets. Based on the latest financial reports, Guangzhou Improve Med Instrument (300030) holds total assets worth CN¥1.02 Billion CNY (≈ $149.71 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Guangzhou Improve Med Instrument (300030) total market value for the company's overall valuation and market capitalisation.
Total Assets of Guangzhou Improve Med Instrument (2006–2025)
Total assets of Guangzhou Improve Med Instrument from 2006 to 2025. This chart illustrates how Guangzhou Improve Med Instrument's total assets have evolved over time, based on quarterly financial data. See Guangzhou Improve Med Instrument stock price for real-time trading data and today's change.
Guangzhou Improve Med Instrument - Asset Composition Analysis
Guangzhou Improve Med Instrument Total Assets Breakdown (December 2025)
Guangzhou Improve Med Instrument total assets breakdown as of December 2025. Guangzhou Improve Med Instrument's total assets of CN¥1.02 Billion consist of 41.2% current assets and 58.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 15.6% |
| Accounts Receivable | CN¥124.26 Million | 12.1% |
| Inventory | CN¥81.15 Million | 7.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥33.71 Million | 3.3% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2006–2025)
This chart illustrates how Guangzhou Improve Med Instrument's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Guangzhou Improve Med Instrument's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guangzhou Improve Med Instrument's current assets represent 41.2% of total assets in 2025, a decrease from 70.3% in 2006.
- Cash Position: Cash and equivalents constituted 15.6% of total assets in 2025, up from 9.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, unchanged from 3.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 12.1% of total assets.
Guangzhou Improve Med Instrument Competitors by Total Assets
Key competitors of Guangzhou Improve Med Instrument based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Caina Technology Co. Ltd.
SHE:301122
|
China | CN¥2.26 Billion |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
Ocumetics Technology Corp
V:OTC
|
Canada | CA$1.15 Million |
|
Osteopore Ltd
AU:OSX
|
Australia | AU$2.77 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.39 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
Guangzhou Improve Med Instrument - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.46 | 1.21 | 1.27 |
| Quick Ratio | 1.15 | 0.95 | 1.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥134.60 Million | CN¥85.02 Million | CN¥165.65 Million |
Guangzhou Improve Med Instrument - Advanced Valuation Insights
This section examines the relationship between Guangzhou Improve Med Instrument's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.28 |
| Latest Market Cap to Assets Ratio | 0.32 |
| Asset Growth Rate (YoY) | -17.5% |
| Total Assets | CN¥1.03 Billion |
| Market Capitalization | $332.54 Million USD |
Valuation Analysis
Below Book Valuation: The market values Guangzhou Improve Med Instrument's assets below their book value (0.32x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Guangzhou Improve Med Instrument's assets decreased by 17.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Guangzhou Improve Med Instrument (2006–2025)
The table below shows the annual total assets of Guangzhou Improve Med Instrument from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.03 Billion ≈ $150.27 Million |
-17.46% |
| 2024-12-31 | CN¥1.24 Billion ≈ $182.06 Million |
-12.75% |
| 2023-12-31 | CN¥1.43 Billion ≈ $208.66 Million |
-8.49% |
| 2022-12-31 | CN¥1.56 Billion ≈ $228.01 Million |
-14.62% |
| 2021-12-31 | CN¥1.83 Billion ≈ $267.06 Million |
+4.60% |
| 2020-12-31 | CN¥1.74 Billion ≈ $255.31 Million |
+15.79% |
| 2019-12-31 | CN¥1.51 Billion ≈ $220.49 Million |
-0.29% |
| 2018-12-31 | CN¥1.51 Billion ≈ $221.13 Million |
-13.44% |
| 2017-12-31 | CN¥1.75 Billion ≈ $255.48 Million |
+18.78% |
| 2016-12-31 | CN¥1.47 Billion ≈ $215.09 Million |
+2.12% |
| 2015-12-31 | CN¥1.44 Billion ≈ $210.62 Million |
+41.20% |
| 2014-12-31 | CN¥1.02 Billion ≈ $149.16 Million |
+15.43% |
| 2013-12-31 | CN¥883.08 Million ≈ $129.22 Million |
+15.20% |
| 2012-12-31 | CN¥766.53 Million ≈ $112.17 Million |
+6.95% |
| 2011-12-31 | CN¥716.72 Million ≈ $104.88 Million |
+10.05% |
| 2010-12-31 | CN¥651.24 Million ≈ $95.30 Million |
-1.00% |
| 2009-12-31 | CN¥657.84 Million ≈ $96.26 Million |
+364.29% |
| 2008-12-31 | CN¥141.69 Million ≈ $20.73 Million |
+91.78% |
| 2007-12-31 | CN¥73.88 Million ≈ $10.81 Million |
+84.93% |
| 2006-12-31 | CN¥39.95 Million ≈ $5.85 Million |
-- |
About Guangzhou Improve Med Instrument
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising feces and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company… Read more